← Leaderboards
Jared Rylan Tangney
Biolinq Incorporated
$2,738,039
Attributed
$2,738,039
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $853.6K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,738,039 · 1
By mechanism
R44$2,738,039 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Insulin”
- Barbara Halina Braffett · George Washington University$22,016,904
- Ionut Bebu · George Washington University$18,816,779
- Michael P Harms · Washington University$13,645,932
- Noel P Burtt · Broad Institute, Inc.$10,557,791
- David N. Wholley · Foundation For The Nih$10,394,136
- Pradeep Natarajan · Massachusetts General Hospital$9,417,826
Research focus
InsulinPerformanceEffectivenessInsightMobile ApplicationMonitorDiabetes ManagementDiabetes MellitusCostHypoglycemiaIntercellular FluidLeadData DisplayDesignDevicesChemistryBiosensorClinical ResearchBlood GlucoseCommercializationGlucoseHormonesDermalResponse
Grant awards (4)
Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes$853,587
R44 · FY2025 · DK · contact PI
A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$786,397
R44 · FY2023 · DK · contact PI
A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$798,715
R44 · FY2022 · DK · contact PI
A Hybrid Continuous Glucose and Lactate Monitor with Improved Signal Reliability$299,340
R44 · FY2021 · DK · contact PI